EPH receptor A5: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 29: Line 29:
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 10:28, 17 March 2025

EPH receptor A5 (EphA5) is a protein that in humans is encoded by the EPHA5 gene. This protein belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.

Function[edit]

EPH receptor A5 plays a critical role in the development of the nervous system. It is involved in the development of nerve connections in the brain, a process known as axon guidance. EphA5 interacts with cell-surface ephrin ligands, triggering signaling cascades that influence cell movement, shape, and attachment. This receptor is particularly important in the formation of the topographic maps in the brain, which are essential for spatial awareness and sensory processing.

In addition to its role in neural development, EphA5 has been studied for its involvement in cancer progression. Alterations in the expression of EphA5 have been observed in various types of cancer, suggesting that it may play a role in tumor growth and metastasis.

Structure[edit]

The structure of EPH receptor A5 includes an extracellular region, consisting of a globular domain, a cysteine-rich domain, followed by two fibronectin type III domains. This is connected to a single transmembrane segment and an intracellular region that contains the tyrosine kinase domain, a sterile alpha motif (SAM), and a PDZ-binding motif. The interaction of EphA5 with its ephrin ligands occurs through the extracellular domain, leading to receptor dimerization and activation of the kinase domain.

Clinical Significance[edit]

Research has indicated that EphA5 may serve as a potential therapeutic target in cancer treatment. Its role in tumor suppression and inhibition of metastasis makes it a candidate for targeted therapy. Additionally, due to its involvement in neural development, EphA5 is being studied in the context of neurodevelopmental disorders and neurodegenerative diseases. Understanding the signaling pathways mediated by EphA5 could lead to new therapeutic strategies for these conditions.

See Also[edit]

References[edit]

<references/>






Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!